C
Concert Pharmaceuticals Inc
F:73C
Concert Pharmaceuticals Inc
F:73C
Price:
7.818
EUR
Market Cap:
€374.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Concert Pharmaceuticals Inc
F:73C
|
US |
|
C
|
Cuscapi Berhad
KLSE:CUSCAPI
|
MY |
|
I
|
Indian Infotech and Software Ltd
BSE:509051
|
IN |
|
A-One Seimitsu Inc
TSE:6156
|
JP |
|
Environmental Waste International Inc
XTSX:EWS
|
CA |
|
Apex Capital and Finance Ltd
BSE:541133
|
IN |
Income Statement
Earnings Waterfall
Concert Pharmaceuticals Inc
Concert Pharmaceuticals Inc
Income Statement
Concert Pharmaceuticals Inc
Concert Pharmaceuticals Inc
Currency: USD
| Dec-2022 | Mar-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(11)
|
(18)
|
(21)
|
(24)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(3)
|
(4)
|
(6)
|
(8)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(12)
|
(13)
|
(13)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
|
| Operating Income |
(0)
N/A
|
(0)
+31%
|
(0)
+74%
|
(0)
+20%
|
(0)
-27%
|
(0)
-286%
|
(11)
-12 385%
|
(18)
-57%
|
(21)
-16%
|
(24)
-15%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+31%
|
(0)
+74%
|
(0)
+38%
|
(0)
-6%
|
(0)
-416%
|
(13)
-16 640%
|
(18)
-33%
|
(20)
-16%
|
(23)
-15%
|
|
| Net Income | |||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
3
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(11)
|
(15)
|
(18)
|
(21)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+31%
|
(0)
+74%
|
(0)
+38%
|
(0)
-6%
|
(0)
-416%
|
(11)
-13 886%
|
(15)
-34%
|
(18)
-19%
|
(21)
-17%
|
|
| EPS (Diluted) |
-0.12
N/A
|
-0.08
+33%
|
-0.02
+75%
|
-0.01
+50%
|
-0.01
N/A
|
-0.08
-700%
|
-0.33
-313%
|
-0.28
+15%
|
-0.34
-21%
|
-0.4
-18%
|
|
Switch to:
Switch to:
See Also
Discover More
